Related Experiment Videos
Functional Genomics meets neurodegenerative disorders Part I: transcriptomic and proteomic technology
Della C David1, Frederic Hoerndli, Jürgen Götz
1Brain and Mind Research Institute, University of Sydney, 100 Mallett St., Camperdown, NSW 2050, Australia.
Progress in Neurobiology
|September 20, 2005
Summary
This review details transcriptomics and proteomics techniques for understanding neurodegenerative disorders. It covers methods like microarrays and mass spectrometry to analyze gene and protein expression for mechanistic insights.
Area of Science:
- Neuroscience
- Genomics
- Proteomics
Background:
- Neurodegenerative disorders require mechanistic understanding.
- Transcriptomics and proteomics offer insights into disease mechanisms.
- Integrated approaches using these techniques are valuable.
Purpose of the Study:
- To review the technical aspects of transcriptomics and proteomics for neurodegenerative disorder research.
- To provide a foundation for understanding the application and integration of these functional genomics tools.
Main Methods:
- Transcriptomics: Discusses qRT-PCR, SAGE, subtractive hybridization, differential display, and microarrays, including laser microcapture dissection and software.
- Proteomics: Covers 2D gel electrophoresis, liquid chromatography, protein/peptide labeling and enrichment, and mass spectrometry.
Main Results:
- Identifies key transcriptomic and proteomic techniques relevant to neurodegenerative research.
- Highlights the technical considerations for applying these methods.
Conclusions:
- Transcriptomics and proteomics are powerful tools for dissecting signaling pathways and networks in neurodegenerative diseases.
- Part I lays the groundwork for Part II, which integrates these methods for disease application.